 |
| A Phase III Randomized, Double-Blind Study Of Sunitinib (SU011248, Sutent) Versus Placebo In Patients With Progressive Advanced/Metastatic Well-Differentiated Pancreatic Islet Cell Tumors. |
| Pancreatica Trial ID: PA-7564 |
|
| Trial Phase |
|
Alternative Drug Names |
|
| Phase 3 |
|
SU11248 , Sunitinib Malate, Sutent |
|
|
| Disease Stage (least advanced) |
|
Tumor Type |
|
| Advanced |
|
Neuroendocrine tumor (e.g. islet-cell tumor) |
|
|
| Treatment |
|
| Chemotherapy or Biological therapy, single agent |
|
|
|
| Drug and Trial Classifications and Mechanisms |
|
| kinase inhibitor (or tyrosine kinase inhibitor) |
|
|
|
| Special Inclusion Criteria |
|
| -Not Specified- |
|
|
| Main Exclusion Criteria |
|
| Liver / kidney function requirements? Not Specified |
| Activity status requirements? Not Specified |
|
|
| Prior Therapy Allowed? |
|
| Chemo or Biological? Selectively Allowed |
| Radiation? Selectively Allowed |
| Surgery? Not Specified |
| Other? Not Specified |
|
|
| Treatment Interval |
|
| Unspecified / Unknown |
|
|
| Sponsors |
|
| Pfizer Pharmaceuticals |
| Pfizer Oncology Clinical Trial Information Service
Phone number: U.S. 1-877-369-9753 |
|
|
| Institutions |
|
|
| Aurora, CO, US |
|
| Holden Comprehensive Cancer Center, University of Iowa |
| Iowa City, IA, US |
|
|
| Chicago , IL, US |
|
|
| Jeffersonville , IN, US |
|
|
| Louisville, KY, US |
|
|
| Shelbyville, KY, US |
|
|
| Kenner , LA, US |
|
|
| New Orleans , LA, US |
|
|
| Worcester, MA, US |
|
| Detroit |
| Detroit, MI, US |
|
|
| Farmington Hills , MI, US |
|
|
| St. Peters, MO, US |
|
|
| Creve Coeur, MO, US |
|
| Siteman Cancer Center at Barnes-Jewish Hospital |
| St Louis , MO, US |
|
|
| Hershey, PA, US |
|
|
| Austin, TX, US |
|
|
| Georgetown, TX, US |
|
|
| Norfolk, VA, US |
|
|
| Redcliffe, Queensland, Australia |
|
|
| Kogarah, New South Wales, Australia |
|
|
| Perth, Western Australia, Australia |
|
|
| Brussels, Belgium |
|
|
| Leuven, Belgium |
|
|
| Halifax, Nova Scotia, Canada |
|
|
| Toronto, Ontario, Canada |
|
|
| Vancouver, British Columbia, Canada |
|
| McGill University |
| Montreal, QC, Canada |
|
|
| Santafe de Bogota, Colombia |
|
|
| Leeds, England |
|
|
| Liverpool, England |
|
|
| Manchester, England |
|
|
| Bordeaux , France |
|
| Pfizer Investigational Site |
| Clichy Cedex, France |
|
|
| Lyon, France |
|
|
| Marseille, France |
|
|
| Paris, France |
|
|
| Heidelberg, Germany |
|
|
| Luebeck, Germany |
|
|
| Bad Berka, Germany |
|
|
| Berlin, Germany |
|
|
| Ulm, Germany |
|
|
| Rozzano , Italy |
|
|
| Barcelona, Spain |
|
|
| Madrid, Spain |
|
|
| Navarra, Spain |
|
|
|
|
